Vico Therapeutics, a neurology-focused genetic medicine company, has appointed Micah Mackison as CEO. Mackison brings significant biotechnology and pharmaceutical leadership experience to Vico. He joins from Locanabio, an RNA-targeted gene therapy company,…






